Experimental and clinical assessment of percutaneous hepatic quantified ethanol injection in treatment of hepatic carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 21

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

345

HTML

2172

Figures (1-6)

131

Tables (1-4)

125

Sum=2773

Nov 1, 2004 (publication date) through Apr 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Nov 1, 2004; 10(21): 3112-3117
Published online Nov 1, 2004. doi: 10.3748/wjg.v10.i21.3112

Table 1 Comparison of TGI between groups (mean ± SD )

¹P > 0.05 vs group B,

^bP < 0.01 vs group C,

^dP < 0.01 vs group A.

Citation: Lin LW, Lin XY, He YM, Gao SD, Xue ES, Lin XD, Yu LY. Experimental and clinical assessment of percutaneous hepatic quantified ethanol injection in treatment of hepatic carcinoma. World J Gastroenterol 2004; 10(21): 3112-3117
URL: https://www.wjgnet.com/1007-9327/full/v10/i21/3112.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i21.3112